{"id":"https://openalex.org/W4415380384","doi":"https://doi.org/10.1093/cid/ciaf496","title":"Estimated Vaccine Effectiveness for Respiratory Syncytial Virus\u2013Related Acute Respiratory Illness in Older Adults: Findings From the First Postlicensure Season","display_name":"Estimated Vaccine Effectiveness for Respiratory Syncytial Virus\u2013Related Acute Respiratory Illness in Older Adults: Findings From the First Postlicensure Season","publication_year":2025,"publication_date":"2025-09-05","ids":{"openalex":"https://openalex.org/W4415380384","doi":"https://doi.org/10.1093/cid/ciaf496","pmid":"https://pubmed.ncbi.nlm.nih.gov/41117531","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13017472"},"language":"en","primary_location":{"id":"doi:10.1093/cid/ciaf496","doi":"https://doi.org/10.1093/cid/ciaf496","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/ciaf496","pdf_url":"https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaf496/64821249/ciaf496.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaf496/64821249/ciaf496.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032804979","display_name":"Sara Yee Tartof","orcid":"https://orcid.org/0000-0003-2336-8476","observed_orcids":["https://orcid.org/0000-0003-2336-8476"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I4405260683","display_name":"Kaiser Permanente Bernard J. Tyson School of Medicine","ror":"https://ror.org/0445kkj20","country_code":"US","type":"education","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4405260683"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sara Y Tartof","raw_affiliation_strings":["Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine , Pasadena, California ,","Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA"],"raw_orcid":"https://orcid.org/0000-0003-2336-8476","affiliations":[{"raw_affiliation_string":"Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine , Pasadena, California ,","institution_ids":["https://openalex.org/I4405260683"]},{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","institution_ids":["https://openalex.org/I1343052199"]},{"raw_affiliation_string":"Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA","institution_ids":["https://openalex.org/I4405260683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046341888","display_name":"Negar Aliabadi","orcid":"https://orcid.org/0000-0002-9264-5089","observed_orcids":["https://orcid.org/0000-0002-9264-5089"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Negar Aliabadi","raw_affiliation_strings":["US Medical Affairs, Pfizer , New York, New York ,","US Medical Affairs, Pfizer, New York, New York, USA"],"raw_orcid":"https://orcid.org/0000-0002-9264-5089","affiliations":[{"raw_affiliation_string":"US Medical Affairs, Pfizer , New York, New York ,","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"US Medical Affairs, Pfizer, New York, New York, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Gabriella Goodwin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriella Goodwin","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","institution_ids":["https://openalex.org/I1343052199"]},{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062829555","display_name":"Jeff M. Slezak","orcid":"https://orcid.org/0000-0002-6108-9198","observed_orcids":["https://orcid.org/0000-0002-6108-9198"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeff Slezak","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA"],"raw_orcid":"https://orcid.org/0000-0002-6108-9198","affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","institution_ids":["https://openalex.org/I1343052199"]},{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031960337","display_name":"Vennis X. Hong","orcid":"https://orcid.org/0000-0002-6060-8419","observed_orcids":["https://orcid.org/0000-0002-6060-8419"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vennis Hong","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","institution_ids":["https://openalex.org/I1343052199"]},{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002800668","display_name":"Bradley K. Ackerson","orcid":"https://orcid.org/0000-0002-0816-7345","observed_orcids":["https://orcid.org/0000-0002-0816-7345"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley Ackerson","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA"],"raw_orcid":"https://orcid.org/0000-0002-0816-7345","affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","institution_ids":["https://openalex.org/I1343052199"]},{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100345256","display_name":"Qing Liu","orcid":"https://orcid.org/0000-0003-3733-9078","observed_orcids":["https://orcid.org/0000-0003-3733-9078"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qing Liu","raw_affiliation_strings":["Data Sciences and Analytics, Pfizer , New York, New York ,","Data Sciences and Analytics, Pfizer, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Sciences and Analytics, Pfizer , New York, New York ,","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Data Sciences and Analytics, Pfizer, New York, New York, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013063227","display_name":"Sally Fontamillas Shaw","orcid":"https://orcid.org/0000-0002-6553-1772","observed_orcids":["https://orcid.org/0000-0002-6553-1772"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sally Shaw","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA"],"raw_orcid":"https://orcid.org/0000-0002-6553-1772","affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","institution_ids":["https://openalex.org/I1343052199"]},{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003633408","display_name":"Sabrina Welsh","orcid":"https://orcid.org/0009-0000-7690-0062","observed_orcids":["https://orcid.org/0009-0000-7690-0062"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sabrina Welsh","raw_affiliation_strings":["Research and Development, Pfizer , New York, New York ,","Research and Development, Pfizer, New York, New York, USA"],"raw_orcid":"https://orcid.org/0009-0000-7690-0062","affiliations":[{"raw_affiliation_string":"Research and Development, Pfizer , New York, New York ,","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Research and Development, Pfizer, New York, New York, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057156734","display_name":"Banshri Kapadia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Banshri Kapadia","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","institution_ids":["https://openalex.org/I1343052199"]},{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049690667","display_name":"Brigitte C. Spence","orcid":"https://orcid.org/0000-0003-2386-9967","observed_orcids":["https://orcid.org/0000-0003-2386-9967"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brigitte C Spence","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA"],"raw_orcid":"https://orcid.org/0000-0003-2386-9967","affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","institution_ids":["https://openalex.org/I1343052199"]},{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015228397","display_name":"Joseph A. Lewnard","orcid":"https://orcid.org/0000-0002-8505-8839","observed_orcids":["https://orcid.org/0000-0002-8505-8839","https://orcid.org/0000-0002-5417-8475"]},"institutions":[{"id":"https://openalex.org/I95457486","display_name":"University of California, Berkeley","ror":"https://ror.org/01an7q238","country_code":"US","type":"education","lineage":["https://openalex.org/I95457486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph A Lewnard","raw_affiliation_strings":["Center for Computational Biology, College of Engineering, University of California , Berkeley, California ,","Division of Epidemiology and Division of Infectious Diseases and Vaccinology, School of Public Health, University of California , Berkeley, California ,","Center for Computational Biology, College of Engineering, University of California, Berkeley, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Computational Biology, College of Engineering, University of California , Berkeley, California ,","institution_ids":["https://openalex.org/I95457486"]},{"raw_affiliation_string":"Division of Epidemiology and Division of Infectious Diseases and Vaccinology, School of Public Health, University of California , Berkeley, California ,","institution_ids":["https://openalex.org/I95457486"]},{"raw_affiliation_string":"Center for Computational Biology, College of Engineering, University of California, Berkeley, California, USA","institution_ids":["https://openalex.org/I95457486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071474969","display_name":"Gregg S Davis","orcid":"https://orcid.org/0009-0008-0709-5838","observed_orcids":["https://orcid.org/0009-0008-0709-5838"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregg S Davis","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA"],"raw_orcid":"https://orcid.org/0009-0008-0709-5838","affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","institution_ids":["https://openalex.org/I1343052199"]},{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003047853","display_name":"Michael Aragones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Aragones","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","institution_ids":["https://openalex.org/I1343052199"]},{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021268492","display_name":"Michael P. Dutro","orcid":"https://orcid.org/0009-0005-7634-2183","observed_orcids":["https://orcid.org/0009-0005-7634-2183"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Dutro","raw_affiliation_strings":["US Medical Affairs, Pfizer , New York, New York ,","US Medical Affairs, Pfizer, New York, New York, USA"],"raw_orcid":"https://orcid.org/0009-0005-7634-2183","affiliations":[{"raw_affiliation_string":"US Medical Affairs, Pfizer , New York, New York ,","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"US Medical Affairs, Pfizer, New York, New York, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052814249","display_name":"Erica Leigh Chilson","orcid":"https://orcid.org/0000-0002-4417-3398","observed_orcids":["https://orcid.org/0000-0002-4417-3398"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erica Chilson","raw_affiliation_strings":["US Medical Affairs, Pfizer , New York, New York ,","US Medical Affairs, Pfizer, New York, New York, USA"],"raw_orcid":"https://orcid.org/0000-0002-4417-3398","affiliations":[{"raw_affiliation_string":"US Medical Affairs, Pfizer , New York, New York ,","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"US Medical Affairs, Pfizer, New York, New York, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110720579","display_name":"Elisa Gonzalez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elisa Gonzalez","raw_affiliation_strings":["Research and Development, Pfizer , New York, New York ,","Research and Development, Pfizer, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Pfizer , New York, New York ,","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Research and Development, Pfizer, New York, New York, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113055027","display_name":"Robin Hubler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robin Hubler","raw_affiliation_strings":["Research and Development, Pfizer , New York, New York ,","Research and Development, Pfizer, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Pfizer , New York, New York ,","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Research and Development, Pfizer, New York, New York, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075087643","display_name":"Luis J\u00f3dar","orcid":"https://orcid.org/0000-0003-1246-530X","observed_orcids":["https://orcid.org/0000-0003-1246-530X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luis Jodar","raw_affiliation_strings":["Independent Advisor, Pfizer , New York, New York ,","Independent Advisor, Pfizer, New York, New York, USA"],"raw_orcid":"https://orcid.org/0000-0003-1246-530X","affiliations":[{"raw_affiliation_string":"Independent Advisor, Pfizer , New York, New York ,","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Independent Advisor, Pfizer, New York, New York, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070628953","display_name":"Bradford D. Gessner","orcid":"https://orcid.org/0000-0002-6216-7194","observed_orcids":["https://orcid.org/0000-0002-6216-7194"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradford D Gessner","raw_affiliation_strings":["EpiVac Consulting, Pfizer , New York, New York ,","EpiVac Consulting, Pfizer, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EpiVac Consulting, Pfizer , New York, New York ,","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"EpiVac Consulting, Pfizer, New York, New York, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077259705","display_name":"Elizabeth M. Begier","orcid":"https://orcid.org/0000-0002-1287-5416","observed_orcids":["https://orcid.org/0000-0002-1287-5416"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Begier","raw_affiliation_strings":["Research and Development, Pfizer , New York, New York ,","Research and Development, Pfizer, New York, New York, USA"],"raw_orcid":"https://orcid.org/0000-0002-1287-5416","affiliations":[{"raw_affiliation_string":"Research and Development, Pfizer , New York, New York ,","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Research and Development, Pfizer, New York, New York, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5032804979"],"corresponding_institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I4405260683"],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":{"value":4763,"currency":"USD","value_usd":4763},"fwci":8.9486,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.98556962,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":100},"biblio":{"volume":"82","issue":"2","first_page":"e361","last_page":"e370"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/respiratory-syncytial-virus","display_name":"respiratory syncytial virus","score":0.9909999966621399},{"id":"https://openalex.org/keywords/rsvpref-vaccine","display_name":"RSVpreF vaccine","score":0.972000002861023},{"id":"https://openalex.org/keywords/abrysvo","display_name":"Abrysvo","score":0.9649999737739563},{"id":"https://openalex.org/keywords/vaccine-effectiveness","display_name":"vaccine effectiveness","score":0.9819999933242798},{"id":"https://openalex.org/keywords/acute-respiratory-illness","display_name":"acute respiratory illness","score":0.9769999980926514},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.9769999980926514},{"id":"https://openalex.org/keywords/post-licensure-surveillance","display_name":"post-licensure surveillance","score":0.6159999966621399},{"id":"https://openalex.org/keywords/emergency-department-visits","display_name":"emergency department visits","score":0.7990000247955322},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.9570000171661377},{"id":"https://openalex.org/keywords/severe-respiratory-illness","display_name":"severe respiratory disease","score":0.6629999876022339},{"id":"https://openalex.org/keywords/vulnerable-populations","display_name":"vulnerable populations","score":0.6290000081062317},{"id":"https://openalex.org/keywords/test-negative-case-control-study","display_name":"test-negative case-control","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9757000207901001},{"id":"https://openalex.org/C2994330797","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory illness","level":3,"score":0.8482000231742859},{"id":"https://openalex.org/C534529494","wikidata":"https://www.wikidata.org/wiki/Q7891","display_name":"Respiratory system","level":2,"score":0.6414999961853027},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.6101999878883362},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3763999938964844},{"id":"https://openalex.org/C2776178081","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory disease","level":3,"score":0.35100001096725464},{"id":"https://openalex.org/C2776012195","wikidata":"https://www.wikidata.org/wiki/Q754447","display_name":"Respiratory tract infections","level":3,"score":0.3472999930381775},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.3301999866962433},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3125999867916107},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.31139999628067017},{"id":"https://openalex.org/C2993183539","wikidata":"https://www.wikidata.org/wiki/Q754447","display_name":"Respiratory infection","level":3,"score":0.30329999327659607},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.29829999804496765},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2759999930858612},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.2718999981880188},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.2712000012397766},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.27079999446868896},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.27079999446868896}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/cid/ciaf496","doi":"https://doi.org/10.1093/cid/ciaf496","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/ciaf496","pdf_url":"https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaf496/64821249/ciaf496.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13017472","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13017472/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13017472/pdf/ciaf496.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Infect Dis","raw_type":"Text"},{"id":"pmid:41117531","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41117531","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/cid/ciaf496","doi":"https://doi.org/10.1093/cid/ciaf496","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/ciaf496","pdf_url":"https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaf496/64821249/ciaf496.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320308849","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415380384.pdf","grobid_xml":"https://content.openalex.org/works/W4415380384.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1980040599","https://openalex.org/W1982855609","https://openalex.org/W1988958782","https://openalex.org/W1989501142","https://openalex.org/W2109801797","https://openalex.org/W2580797815","https://openalex.org/W2754200907","https://openalex.org/W2803929185","https://openalex.org/W2900550358","https://openalex.org/W2903306912","https://openalex.org/W3098825314","https://openalex.org/W4220727497","https://openalex.org/W4311749128","https://openalex.org/W4318262687","https://openalex.org/W4320892455","https://openalex.org/W4328047971","https://openalex.org/W4362603786","https://openalex.org/W4376226427","https://openalex.org/W4380422476","https://openalex.org/W4384926015","https://openalex.org/W4387378185","https://openalex.org/W4399969935","https://openalex.org/W4401364142","https://openalex.org/W4401910138","https://openalex.org/W4402221760","https://openalex.org/W4403463212","https://openalex.org/W4403506189","https://openalex.org/W4404345746","https://openalex.org/W4405365707","https://openalex.org/W4406607114","https://openalex.org/W4406946324","https://openalex.org/W4407468699","https://openalex.org/W4408808214","https://openalex.org/W4409249489","https://openalex.org/W4409577775","https://openalex.org/W4410217520"],"related_works":["https://openalex.org/W4405365707","https://openalex.org/W7162509605","https://openalex.org/W4416704293","https://openalex.org/W4402870303","https://openalex.org/W7130416789","https://openalex.org/W4406940873","https://openalex.org/W7213539424","https://openalex.org/W4415601799","https://openalex.org/W4327935465","https://openalex.org/W7168132965"],"abstract_inverted_index":{"BACKGROUND:":[0],"Respiratory":[1],"syncytial":[2],"virus":[3],"(RSV)":[4],"is":[5],"an":[6],"important":[7],"cause":[8],"of":[9,65,83,163,177,276],"severe":[10,52,116,231,264,277],"respiratory":[11,28,46,118,220],"illness":[12,47],"among":[13,54,168,192,259],"older":[14,36,245],"adults.":[15,37],"Previously,":[16],"we":[17,39],"showed":[18],"that":[19],"the":[20,105,202,273],"RSVpreF":[21,131,247],"vaccine":[22],"(Abrysvo;":[23],"Pfizer)":[24],"prevents":[25],"RSV-related":[26,252],"lower":[27],"tract":[29],"disease-related":[30],"emergency":[31],"department":[32],"(ED)":[33],"visits/hospitalizations":[34,156],"in":[35,104],"Here,":[38],"evaluate":[40],"its":[41],"effectiveness":[42,139],"against":[43,251,263],"additional":[44],"acute":[45,117],"(ARI)":[48],"end":[49],"points,":[50],"including":[51,258],"disease,":[53],"high-risk":[55,260],"persons.":[56],"METHODS:":[57],"This":[58],"was":[59,130,141,182],"a":[60,125],"retrospective":[61],"test-negative":[62],"case-control":[63],"study":[64],"adults":[66],"aged":[67],"\u226560":[68],"years":[69],"at":[70,272],"Kaiser":[71],"Permanente":[72],"Southern":[73],"California":[74],"with":[75,157,175,194,211,230],"ARI":[76,136,154,253],"ED":[77,155,235,256],"visits/hospitalizations,":[78],"defined":[79],"by":[80],"International":[81],"Classification":[82],"Diseases,":[84],"Tenth":[85],"Revision":[86],"discharge":[87],"code,":[88],"from":[89,143],"24":[90],"November":[91],"2023":[92],"to":[93],"9":[94],"April":[95],"2024.":[96],"Case":[97],"patients":[98,164,193],"tested":[99,108],"positive":[100,123],"for":[101,110,124],"RSV.":[102],"Controls":[103],"primary":[106],"analysis":[107],"negative":[109],"RSV,":[111],"human":[112],"metapneumovirus,":[113],"influenza,":[114],"and":[115,122,228,262],"syndrome":[119],"coronavirus":[120],"2":[121],"non-vaccine-preventable":[126],"pathogen.":[127],"The":[128,179],"exposure":[129],"receipt":[132],"\u226521":[133],"days":[134],"before":[135],"diagnosis.":[137],"Vaccine":[138],"(VE)":[140],"calculated":[142],"adjusted":[144,180],"odds":[145],"ratios":[146],"via":[147],"multivariable":[148],"logistic":[149],"regression.":[150],"RESULTS:":[151],"Overall,":[152],"8965":[153],"RSV":[158,166,266],"testing":[159],"were":[160,165],"included;":[161],"7.8%":[162],"positive,":[167],"whom":[169],"0.3%":[170],"had":[171],"received":[172],"RSVpreF,":[173],"compared":[174],"3.6%":[176],"controls.":[178],"VE":[181,191,250],"92%":[183,241],"(95%":[184],"confidence":[185,199],"interval,":[186],"64%-98%).":[187],"We":[188],"estimated":[189],"similar":[190],"risk":[195,275],"conditions":[196],"(92%":[197],"[95%":[198],"interval:":[200],"65%-98%]),":[201],"oldest":[203],"subgroup":[204],"(age":[205],"\u226575":[206],"years;":[207],"95%":[208],"[60%-99%]),":[209],"those":[210,229],"critical":[212],"outcomes":[213],"(intensive":[214],"care":[215],"unit":[216],"admission,":[217],"mechanical":[218],"ventilation,":[219],"failure,":[221],"vasopressor":[222],"use,":[223],"or":[224,237,255],"death;":[225],"90%":[226],"[16%-99%]),":[227],"disease":[232],"(defined":[233],"as":[234],"visit":[236],"hospitalization":[238,254],"requiring":[239],"oxygen;":[240],"[35%-99%]).":[242],"CONCLUSIONS:":[243],"Among":[244],"adults,":[246],"demonstrated":[248],"high":[249],"visits,":[257],"subgroups,":[261],"outcomes.":[265],"vaccination":[267],"programs":[268],"can":[269],"protect":[270],"groups":[271],"highest":[274],"disease.":[278]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2025-10-22T00:00:00"}